TENGION
- Country
- πΊπΈUnited States
- Ownership
- -
- Established
- 2003-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.tengion.com/
Clinical Trials
8
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)β’ Click on a phase to view related trials
A Phase 1, Open-label Safety Study of NKA in Patients With Type 2 Diabetes
- Conditions
- Chronic Kidney Disease
- First Posted Date
- 2013-12-11
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- Tengion
- Target Recruit Count
- 1
- Registration Number
- NCT02008851
- Locations
- πΊπΈ
University of Chicago Medicine, Chicago, Illinois, United States
πΊπΈLSU Health Care Services, New Orleans, Louisiana, United States
πΊπΈBrigham & Women's Hospital, Boston, Massachusetts, United States
Study of an Autologous Neo-Kidney Augment in Patients With Chronic Kidney Disease
- Conditions
- Chronic Kidney Disease
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- Tengion
- Target Recruit Count
- 6
- Registration Number
- NCT01846715
- Locations
- πΈπͺ
Karolinska Institute, Stockholm, Sweden
πΈπͺUppsala University Hospital, Uppsala, Sweden
Incontinent Urinary Diversion Using an Autologous Neo-Urinary Conduit
- Conditions
- Bladder Cancer
- First Posted Date
- 2010-03-16
- Last Posted Date
- 2014-12-10
- Lead Sponsor
- Tengion
- Target Recruit Count
- 8
- Registration Number
- NCT01087697
- Locations
- πΊπΈ
The University of Chicago, Chicago, Illinois, United States
πΊπΈThe Johns Hopkins Medical Institutions, Baltimore, Maryland, United States
πΊπΈBrigham and Women's Hospital, Boston, Massachusetts, United States
Multi Center Study to Obtain Bladder Tissue Specimens From Patients Undergoing Transurethral Resection Biopsy Procedure
- Conditions
- Bladder Disease
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2010-12-22
- Lead Sponsor
- Tengion
- Target Recruit Count
- 6
- Registration Number
- NCT00615043
- Locations
- πΊπΈ
University of Alabama, Birmingham, Birmingham, Alabama, United States
Autologous Neo-Bladder Construct in Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence
- Conditions
- Overactive Bladder
- First Posted Date
- 2008-01-15
- Last Posted Date
- 2018-06-08
- Lead Sponsor
- Tengion
- Registration Number
- NCT00594139
- Locations
- πΊπΈ
Vanderbilt University, Nashville, Tennessee, United States
- Prev
- 1
- 2
- Next